Navigation Links
PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations
Date:12/6/2012

Taft Center for Clinical Research.  

Eligibility criteria include:

  • Unfunded or modestly funded innovators who need support building the technical and/or business validation needed to attract an initial round of financing (typically an "A-round")
  • Individuals or small teams
  • Innovators who, while they are working on their idea with the support of the Fogarty Institute, are able to work at the Fogarty Institute facility in Mountain View, CA
  • Innovators who will significantly benefit from the unique educational resources (e.g. mentoring and clinical access) provided by the Institute
  • Innovators whose ideas address a major unmet clinical need, or provide an opportunity to significantly improve an existing treatment method

Applications for the Innovator Support Program are due January 9, 2013, and an application and instructions can be found online at: http://www.fogartyinstitute.org/innovation.html

About The Fogarty Institute for Innovation
The Fogarty Institute for Innovation is 501(c)3 educational  non-profit organization that serves to improve patient care by supporting medical  innovation. Its educational activities involve teaching the skills and methodology necessary for medical innovators to translate their ideas into new patient therapies. The Institute and its affiliated Taft Center for Clinical Research are located on the campus of El Camino Hospital in Mountain View, Calif. To learn more about our organization, visit www.fogartyinstitute.org.

About El Camino Hospital
El Camino Hospital is an acute-care, 443-bed, not-for-profit and locally governed organization with campuses in Mountain View and Los Gatos, Calif.  In addition to state-of-the-art emergency departments, key medical specialties includ
'/>"/>

SOURCE El Camino Hospital
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
2. Medical Sales College Boasts An 81.99% Placement Rate For 2011 Graduates
3. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
4. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
5. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
6. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
7. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
8. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
11. The Rogosin Institute and Hebrew Home Collaborate to Provide New Dialysis Service for Residents and Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014  Sprout Pharmaceuticals today announced positive preliminary results from ... with flibanserin up to 200 mg at bedtime had no ... the 20 th Annual Fall Scientific Meeting of the ... in Miami . The Phase ... Response Letter and the Formal Dispute Resolution that was filed ...
(Date:11/22/2014)... 21 de noviembre de 2014  BioClinica®, Inc., ... externalizados y tecnologías eClinical, ha indicado un aumento ... inteligente, para el seguimiento basado en el riesgo ... el concepto del seguimiento basado en el riesgo ... visitas de seguimiento o cambio de los métodos ...
(Date:11/22/2014)... , Nov. 21, 2014 MEDITE Group acquired ... nine months and the 3 rd quarter sales ended ... income was $448,000 for the nine months ended September 2014 ... "Even though our 3 rd quarter is usually a ... extends from July into September for many countries worldwide, we ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3
... ("Volition" or the "Company"), a life sciences company focused on ... shareholders from Cameron Reynolds, CEO: Dear Shareholders, ... growing and the fact that we have been reaching our ... and look forward to future goals that will continue to ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ... and infectious diseases, announced today that VGX-3100, its investigational ... by human papillomavirus, was highlighted by Fierce Vaccines ... (see VGX-3100 – Cervical cancer). Inovio is currently ...
Cached Medicine Technology:VolitionRX Limited Issues Update Letter to Shareholders 2VolitionRX Limited Issues Update Letter to Shareholders 3VolitionRX Limited Issues Update Letter to Shareholders 4VolitionRX Limited Issues Update Letter to Shareholders 5Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 2Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 3Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 4Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 5Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 6
(Date:11/24/2014)... The Mesothelioma Applied Research Foundation ... on Malignant Mesothelioma from March 2nd through March 4th ... take place on the campus of the National Institutes ... dinner and an awards ceremony, will be held at ... range of topics about pleural and peritoneal mesothelioma, treatments, ...
(Date:11/24/2014)... November 24, 2014 A new ... London's pre-eminent pain-relief service and massage therapy provider, ... Massage (ESM). This newest sports massage ... key difference between traditional sports massage and ESM ... the body's very own "reset button,” and ESM ...
(Date:11/24/2014)... SWAccessControl.com has recently released a new collection of ... company is a leading online supplier in the international market. ... at discounted prices, up to 30% off. , “We are ... time, all of our items are offered at low rates. ... I have confidence in our fresh assortment. You will have ...
(Date:11/24/2014)... CO, and Philadelphia, PA (PRWEB) November 24, 2014 ... provider of care coordination and disease management services ... has chosen to implement Essette’s Medical Management software ... new Essette SaaS platform in a program to ... Essette suite includes Population Health Management, Care Management, ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
Breaking Medicine News(10 mins):Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 3Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4
... March 31 A new study in The ... benefits for nurses and patients when continuous vigilance monitoring ... were definitive," stated Dr. Patrick Sullivan, President and CEO ... an early alert to RNs about potential patient deterioration ...
... , - "Thinking Outside ... , Elsevier, a leading ... in the Elsevier Article 2.0 Contest (, http://www.article20.elsevier.com ... useful solutions for rendering journal articles on the,web. ...
... employers across North Carolina , ... Englewood, CO (Vocus) ... life science careers and information, unveiled the seventh edition of the ... , ,This regional campaign is a promotional effort highlighting biotechnological, pharmaceutical ...
... $25 Monthly Fee for Copayments , ... Mineola, NY ... the nation,s lowest cost provider of merchant services, is pleased to ... doctors, dentists, chiropractors, podiatrists and other health care professionals., , ,The ...
... Government Facilities Offer Greater Work-Life Balance , ... Alpharetta, ... recent LocumTenens.com physician survey, only 11% had not worked ... of respondents, most (82%) said they were interested in trying government ...
... China, March 31 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... (Nasdaq: CSKI ), a,leading fully integrated ... of China ("PRC"), today announced that it has,cancelled ... a.m. EDT,on March 31, 2009. The Company will ...
Cached Medicine News:Health News:Continuous Vigilance Monitoring Technology Benefits Nurses & Patients 2Health News:Three Prize Winners Awarded in Elsevier's Article 2.0 Contest 2Health News:Three Prize Winners Awarded in Elsevier's Article 2.0 Contest 3Health News:BioSpace Launches the 2009 Bio NC™ Hotbed Campaign 2Health News:EnablePay Announces Special Payments Processing Program for Doctors, Dentists And Other Health Care Professionals 2Health News:Physician Survey Highlights Advantages of Government Locum Tenens Jobs 2Health News:Physician Survey Highlights Advantages of Government Locum Tenens Jobs 3Health News:China Sky One Medical, Inc. Delays Fourth Quarter and Full Year 2008 Earnings Conference Call 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: